Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Companies

Bristol Myers Squibb Co.

S&P 100S&P 500Health CarePharmaceutical PreparationsNYSE

Ticker BMY. 40 dated commitments on record, 4 still open or being checked. History read from 2016, last updated 10 Oct 2026.

Execution profile

Commitments recorded
40
4 open
Clear outcomes
21
16 met · 3 late or partly · 2 not met or withdrawn
Delivered by the original date
76%
of 21 clear outcomes, all years on record
Commitments restated
0
no deadline pushed later
Targets reduced
0
wording weakened: 0
No public record found
15
never counted for or against

Separate measures of what Bristol Myers Squibb Co. said and what the public record showed, from 40 commitments. Every entry is listed below with its sources. How outcomes are decided

Kept Scores are not yet published

We are building the verified historical record first. Scores will be published once there is enough hand-checked history for them to mean something, and the methodology will be fixed and dated before the first score appears. This company has 6 commitments with a clear outcome in the last 3 years (the Kept Score window); the execution profile covers all years on record. How the score will work

Bristol Myers Squibb Co.'s complete recordEvery commitment, outcome and evidence link as a report and spreadsheet. Checked by a person, emailed within one business day · $49

Get the report · $49 Follow free by email

Coming due

Dated commitments Bristol Myers Squibb Co. announced whose deadlines fall in the next six months. After each deadline, and a 30-day allowance, we check what the public record shows.

  1. 31 Dec 2026Report pivotal data for RYZ101 in first-line extensive-stage small cell lung cancer
  2. 31 Dec 2026Report data from the registrational clinical trials for KarXT for Alzheimer’s disease psychosis
  3. 31 Dec 2026Report Phase 3 data readout for Alzheimer's psychosis (KarXT/Cobenfy) in 2026

Compared with its sector

76% of Bristol Myers Squibb Co.'s commitments with a clear outcome were delivered by the original date: below the Health Care median of 90%, across 11 S&P 500 Health Care companies with enough outcomes to compare (rank 8 of 11).

Median across the S&P 500: 78%. A count of outcomes, not a Kept Score or a rating. See every S&P 100 company

Commitments

  • Deadline
  • Met
  • Late
  • Not met
  • Today

Get Bristol Myers Squibb Co.'s full record

Every commitment, outcome, evidence link and restatement as a report and spreadsheet, checked by a researcher against the SEC filings and emailed within one business day of payment.

Get the report · $49

Is this your company?

This page is public and free. Claim it to get a reminder before each deadline Bristol Myers Squibb Co. announced, add your own sources to any entry, and receive a quarterly summary compared with your sector.

Claim this page

Does something on this page need correcting? Bristol Myers Squibb Co. and any reader can ask us to check an entry, with a link to a public source.

Report an error Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.